Archrock (AROC) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Archrock, Inc. AROC. The stock has moved higher by 7.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider AROC’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as AROC has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Archrock, Inc. (AROC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
